James Goodhand
James Goodhand
Royal Devon and Exeter NHS Foundation Trust
Verified email at
Cited by
Cited by
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study
NA Kennedy, GA Heap, HD Green, B Hamilton, C Bewshea, GJ Walker, ...
The lancet Gastroenterology & hepatology 4 (5), 341-353, 2019
HLA-DQA1* 05 carriage associated with development of anti-drug antibodies to infliximab and adalimumab in patients with Crohn’s disease
A Sazonovs, NA Kennedy, L Moutsianas, GA Heap, DL Rice, M Reppell, ...
Gastroenterology 158 (1), 189-199, 2020
Mood disorders in inflammatory bowel disease: relation to diagnosis, disease activity, perceived stress, and other factors
JR Goodhand, M Wahed, JE Mawdsley, AD Farmer, Q Aziz, DS Rampton
Inflammatory bowel diseases 18 (12), 2301-2309, 2012
Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD
NA Kennedy, S Lin, JR Goodhand, N Chanchlani, B Hamilton, ...
Gut 70 (10), 1884-1893, 2021
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab
NA Kennedy, JR Goodhand, C Bewshea, R Nice, D Chee, S Lin, ...
Gut 70 (5), 865-875, 2021
Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel disease
JR Goodhand, N Kamperidis, A Rao, F Laskaratos, A McDermott, ...
Inflammatory bowel diseases 18 (3), 513-519, 2012
Systematic review: Clostridium difficile and inflammatory bowel disease
JR Goodhand, W Alazawi, DS Rampton
Alimentary pharmacology & therapeutics 33 (4), 428-441, 2011
Adolescents with IBD: the importance of structured transition care
J Goodhand, CR Hedin, NM Croft, JO Lindsay
Journal of Crohn's and Colitis 5 (6), 509-519, 2011
Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case-matched observational study
JR Goodhand, FIS Greig, Y Koodun, A McDermott, M Wahed, ...
Inflammatory bowel diseases 18 (7), 1232-1239, 2012
Association of genetic variants in NUDT15 with thiopurine-induced myelosuppression in patients with inflammatory bowel disease
GJ Walker, JW Harrison, GA Heap, MD Voskuil, V Andersen, ...
Jama 321 (8), 773-785, 2019
COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study
JL Alexander, NA Kennedy, H Ibraheim, S Anandabaskaran, A Saifuddin, ...
The lancet Gastroenterology & hepatology 7 (4), 342-352, 2022
Exclusive enteral nutrition provides an effective bridge to safer interval elective surgery for adults with Crohn's disease
N Heerasing, B Thompson, P Hendy, GA Heap, G Walker, R Bethune, ...
Alimentary pharmacology & therapeutics 45 (5), 660-669, 2017
Inflammatory bowel disease in young people: the case for transitional clinics
J Goodhand, R Dawson, M Hefferon, N Tshuma, G Swanson, M Wahed, ...
Inflammatory bowel diseases 16 (6), 947-952, 2010
Massively parallel variant characterization identifies NUDT15 alleles associated with thiopurine toxicity
CC Suiter, T Moriyama, KA Matreyek, W Yang, ER Scaletti, R Nishii, ...
Proceedings of the National Academy of Sciences 117 (10), 5394-5401, 2020
Factors associated with thiopurine non‐adherence in patients with inflammatory bowel disease
JR Goodhand, N Kamperidis, B Sirwan, L Macken, N Tshuma, Y Koodun, ...
Alimentary pharmacology & therapeutics 38 (9), 1097-1108, 2013
Does psychological counseling alter the natural history of inflammatory bowel disease?
M Wahed, M Corser, JR Goodhand, DS Rampton
Inflammatory bowel diseases 16 (4), 664-669, 2010
Real-world effectiveness of tofacitinib for moderate to severe ulcerative colitis: a multicentre UK experience
S Honap, D Chee, TP Chapman, M Patel, AJ Kent, S Ray, E Sharma, ...
Journal of Crohn's and Colitis 14 (10), 1385-1393, 2020
Management of stress in inflammatory bowel disease: a therapeutic option?
JR Goodhand, M Wahed, DS Rampton
Expert review of gastroenterology & hepatology 3 (6), 661-679, 2009
Integrated models of care in managing inflammatory bowel disease: a discussion
AA Mikocka-Walus, JM Andrews, CN Bernstein, LA Graff, JR Walker, ...
Inflammatory bowel diseases 18 (8), 1582-1587, 2012
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab
S Lin, NA Kennedy, A Saifuddin, DM Sandoval, CJ Reynolds, RC Seoane, ...
Nature communications 13 (1), 1379, 2022
The system can't perform the operation now. Try again later.
Articles 1–20